This forecasting supplement, which complements a general guidance document Quantification of Health Commodities: A Guide to Forecasting and Supply Planning for Procurement, will assist program managers, service providers, and technical experts when conducting quantification of needs for priority reproductive, maternal, newborn, and child health medical products. It has been updated to include new products and recommendations from WHO.

This revision includes a significantly enhanced chapter on Postpartum Hemorrhage (PPH), along with improved forecasting algorithms and Excel-based tools—with and without examples—to better support country teams in quantifying priority RMNCH medical products, many of which are underutilized or newly recommended. 

Key Updates and Revisions: 

This latest version reflects 2023 World Health Organization (WHO) recommendations for PPH prevention, diagnosis and treatment, which emphasize two major changes: 

  1. The routine, objective measurement of postpartum blood loss using tools such as calibrated drapes for timely detection of PPH. 
  2. The use of a standardized care bundle that includes uterine massage, administration of uterotonic and tranexamic acid (TXA), IV fluids, genital tract examination, and escalation of care where necessary. 

To align with these updated recommendations and enhance usability, the following changes have been made: 

  • PPH chapter fully updated to include: 
    • Calibrated drapes for blood loss detection 
    • TXA along with other uterotonics for PPH treatment  
    • Heat stable carbetocin as an alternative for prevention of PPH
  • Forecasting algorithms, tools (templates), and tools with examples are updated to incorporate template for the forecasting of calibrated drapes, heat stable carbetocin with other uterotonics for prevention of PPH, and the use of TXA with other uterotonics for PPH treatment. 

These updates are intended to strengthen the country and partner teams’ ability to produce accurate and actionable forecasts, contributing to improved availability of lifesaving RMNCH commodities at all levels of care.